Theresearchers developed a micro-simulation of type 2 diabetes burden from 2018 to 2030 across 221 countries using data from the International Diabetes Federation for prevalence projections and from 14 cohort (group of people with shared characteristics) studies representing more than 60 percent of the global type 2 diabetes population for haemoglobin, treatment, and bodyweight data.
By 2030, 79 million adults with type 2 diabetes are expected to need insulin to manage their condition and if current levels of access remain, only half of them will be able to be able to get an adequate supply, according to CNN.
According to a new study, these changes will cause a dramatic increase in the number of people living with diabetes. Over half of them will be living in just three countries - China, India and the United States. Assuming insulin access remains the same in 2030 as it is today, the study found that type 2 diabetics in Africa and Asia will have the greatest unmet needs. Insulin treatment is expensive and the market is now dominated by three manufacturers, according to the study.
During that time, the biggest spike in need could come from Africa, where experts predict the number of people with type 2 diabetes will jump from 700,000 to over 5 million. In 2017, diabetes patients sued those companies for driving up insulin prices.
By 2030, an estimated 79 million adults with Type 2 diabetes are expected to need insulin. Their study was published Tuesday in The Lancet Diabetes & Endocrinology journal.
Dr Sanjay Basu from Stanford University, USDespite the UN's commitment to treat non-communicable diseases and ensure universal access to drugs for diabetes, across much of the world insulin is scarce and unnecessarily hard for patients to access. There will be an increase in the number of adults with Type 2 diabetes in the coming 12 years due to ageing, urbanization, and related substitutes in diet and physical activity. Only three manufacturers control most of the insulin supply of the world, all of which were accused of conspiring to hike prices intentionally. Unless governments commence inventiveness to make insulin accessible and economical, then its application is going to be far from appropriate.